Guide to Giving
MEDIA, JOBS & RESOURCES FOR THE COMMON GOOD

Kidney Health Australia

Contact

Name: Susan Sayer

Position: National Development and Bequest Manager

Email: susan.sayer@kidney.org.au

Address

125 Cecil St

South Melbourne

Melbourne 3205

Share us on social media

Our Mission / Objective

Kidney Health Australia’s mission is to promote good kidney healthy through education, advocacy, research and support.

Our vision is to save and improve the lives of Australians affected by kidney disease.

Our Services

Kidney Health Information Service (KHIS), offering information, support and referral via a free call line, 1800 4 KIDNEY (543 639) Kidney Kids Programs – Camps and Activities Consumer Participation and Advocacy Strategy, committees in each state identifying and addressing relevant issues Patient/Carer/Health Professional Forums Adult Holiday Program Kidney Check Australia Taskforce (KCAT) a national primary care education program Organ Donation Awareness Kidney Connect, a peer support program and also a kidney care program F.A.I.T.H. (Family Accommodation Initiative Transplant Housing)

Our Beneficiaries

The Australian Community

Projects in Progress

KEY Continuous Research projects into the area of kidney health Events: Kidney Kar Rally Big Red BBQ Golf Day

 

Our People

CEO

Rosanna Care - Interim Chief Executive Officer, Chief Financial Officer and Company Secretary,

Leadership Team

Rosanna Care – Interim Chief Executive Officer, Chief Financial Officer and Company Secretary.

Luke Toy – General Manager Advocacy.

Kendall Vine – General Manager Business Revenue.

Debbie Fortnum – General Manager Education. 

Dr Marie Ludlow BA (Hons) PhD – General Manager Health Outcomes and Evaluation. 

Anne Revell – General Manager Support. 

Names of Board Members

Kidney Health Australia Board of Directors

 

Mr David Morgan BA (Hons), M Int Law

Mr Morgan was appointed interim chair of the Board March 2016.

He retired from the Department of Foreign Affairs and Trade in 2014. He served overseas as a diplomat and represented Australia in international trade and environment organisations. His policy experience includes helping to develop Australia’s gene technology regime and other health and safety issues. From 2004 – 2009 Mr Morgan was a Visiting Fellow at the University of Melbourne.  He is the author/co-author of books and journal articles on the legal, economic and political aspects of biotechnology and other trade and environment issues. Mr Morgan is the Chair of the Emorgo Foundation and a Director of the Victorian Bridge Association. He received a kidney from his father in 1989.

 

Professor Allan Collins MD, FACP (Minnesota USA)

Professor Collins was appointed to the Board in December 2009.

With a distinguished background in nephrology and public health, he is the immediate past president of the National Kidney Foundation (NKF) and professor of medicine at the University of Minnesota School of Medicine, Hennepin County Medical Centre in Minneapolis. He also serves as a director of the Chronic Disease Research Group of the Minneapolis Medical Research Foundation and as principal investigator for the US Renal Data System Coordinating Centre of the National Institutes of Health. As the director of the NKF’s Kidney Early Evaluation Program (KEEP) Coordinating Centre, Professor Collins manages all data resulting from the KEEP screening programs nationwide. Professor Collins is also principal investigator for the Centres for Disease Control and Prevention’s chronic kidney disease detection program at state level. He has also participated in the World Health Organisation Research Agenda for Non-Communicable Diseases planning group and the Field Protocol Development Group for non-communicable disease management in low resource settings.

 

Professor Jonathan Craig PhD, MMed, FRACP, DipCH, MBChB

Professor Craig was appointed to the Board on 16 December 2011.

He is currently Honorary Medical Officer consultant at the Royal Prince Alfred Hospital; director of the Clinical Epidemiology Program at the School of Public Health, University of Sydney; senior staff specialist nephrology at the Children’s Hospital Westmead; co-chair of the Cochrane Collaboration; head of clinical research at the Centre for Kidney Research, Children’s Hospital, Westmead; and a member of the Protocol Advisory Sub-Committee of the Medical Services Advisory Committee.

 

Mr Peter Jon Hartshorne

Mr Hartshorne was appointed to the Board in April 2008.

He is currently managing partner and founder of The Infinity Group of companies (established 1994), a private professional services firm in Australia, India and UK. He is also chairman of Scholaris International Ltd, an international education-based software company, and Redgum Corporate Pty Ltd. Mr Hartshorne began his career with a six-year cadetship with McKinsey and Co and went on to work for many top 100 international companies in the areas of strategy and technology enablement. o Mr Hartshorne was appointed Acting Chair of the Audit and Risk Committee in March 2016.

 

Mr Graeme Holmes BEc, MBA

Mr Holmes was appointed to the Board in May 2007.

He has more than 30 years domestic and international experience in business and strategic planning and general management, industrial relations and strategic human resource management. As well as his years of work with Kidney Health Australia, Mr Holmes contributes his expertise to assist the charitable organisation the Prahran Mission. He is a member of our Audit and Risk Management Committee.

 

Mr Peter Mitchell

Mr Mitchell was appointed to the Board in May 2007.

He is currently commercial adviser to FMT Worldwide, an Australian-based software company. He also served for ten years on the Australian Advisory Board of the insurance group AIG International. His career spans 52 years in finance with the Commonwealth Bank and Perpetual Private Clients. Mr Mitchell was a long-serving committee member and board member of the Melbourne Cricket Club. He has also previously been a board member for seven years with Kids Help Line Australia and three years as a board member with the Lasallian Foundation (Asia Pacific).

 

Mr David Parker AM

Mr Parker was appointed to the Board in April 2010.

He is currently deputy secretary at the Department of Sustainability, Environment, Water, Population and Communities with particular responsibility for the Water Group, which leads the development and implementation of national policies and programs to achieve more sustainable management of Australia’s water resources. Mr Parker was formerly a member of the Executive Board of the Commonwealth Treasury, with responsibility as executive director of the Revenue Group and also as chair of the Treasury Audit Committee. His career at the Treasury spanned from 1984 until February 2011 and includes a period working with the OECD in Paris. Mr Parker was made a Member of the Order of Australia in January 2012.

 

Professor Carol Pollock MB BS PhD FRACP

Professor Carol Pollock was appointed to the Board in December 2014.

She trained as a specialist in Renal Medicine, and gained her PhD in renal physiology in 1992. She was appointed to the Professorial Chair of Medicine, University of Sydney, Royal North Shore Hospital in 2000. She is inaugural Chairman of the Board of the Northern Sydney Local Health District, which has oversight of 6 hospitals and the health of 1.7 million people in New South Wales. She is immediate past Chair, and currently serves on the Boards of the NSW Clinical Excellence Commission and the NSW Agency for Clinical Innovation.  She has published over 220 papers in the scientific literature. She was twice awarded the Australian and New Zealand Society of Nephrology (ANZSN) Young Investigator Award and in 2001 was awarded the highest scientific recognition of the ANZSN, the TJ Neale award. She has previously been a member of the NSW Ministerial Advisory Council for Science and Medical Research and regularly serves on the National Health and Medical Research Council Committees, both as a member and panel Chairman. She has been a member of the Executive Committee of the International Society of Nephrology and is the Scientific Chairman of the World Congress of Nephrology meeting to be held in Hong Kong in 2013. She serves on the Board of several not-for-profit organisations in the Health and Medical Research sector.

 

Mr Vin Harink B Bus, CA

Mr Haring was appointed to the Board in December 2004 (Appointed Chairman April 2010,  resigned March 2016).

He is currently a director of Colvin Management Pty Ltd, a consulting company in the property and finance sectors, and a director of Altus Traffic Pty Ltd. Until July 2008 he was the Chief Executive Officer of Austock Property Funds Management Limited and subsidiary entities. Mr Harink has more than 20 years experience in corporate finance, mergers and acquisitions and capital markets, as a director of Austock Corporate Finance Limited, a partner with Deloitte Touche Tohmatsu, a director of Deloitte Corporate Finance Limited and a director of KPMG Corporate Finance Pty Limited. Mr Hanrink is a member of the Audit and Risk Committee and Remuneration Committee.

Registration Information

ABN

37 008 464 426

Tax Deductible

Yes

How to help us

Wills and Bequests

By remembering Kidney Health Australia in your will, you will be making a considerable difference to the lives of people with kidney disease and their families. It’s a way of showing that you care, knowing that your generosity will be remembered and appreciated. Details on how to leave a bequest, and appropriate wording for your will, visit our website www.kidney.org.au

 

Work with us

Volunteer with us

Volunteers provide valuable assistance in a variety of areas , including supporting administrative and fundraising projects.

 

Our Annual Reports

Our Mission / Objective

Kidney Health Australia’s mission is to promote good kidney healthy through education, advocacy, research and support.

Our vision is to save and improve the lives of Australians affected by kidney disease.

Our Services

Kidney Health Information Service (KHIS), offering information, support and referral via a free call line, 1800 4 KIDNEY (543 639) Kidney Kids Programs – Camps and Activities Consumer Participation and Advocacy Strategy, committees in each state identifying and addressing relevant issues Patient/Carer/Health Professional Forums Adult Holiday Program Kidney Check Australia Taskforce (KCAT) a national primary care education program Organ Donation Awareness Kidney Connect, a peer support program and also a kidney care program F.A.I.T.H. (Family Accommodation Initiative Transplant Housing)

Our Beneficiaries

The Australian Community

Projects in Progress

KEY Continuous Research projects into the area of kidney health Events: Kidney Kar Rally Big Red BBQ Golf Day

 

Our People

CEO

Rosanna Care - Interim Chief Executive Officer, Chief Financial Officer and Company Secretary,

Leadership Team

Rosanna Care – Interim Chief Executive Officer, Chief Financial Officer and Company Secretary.

Luke Toy – General Manager Advocacy.

Kendall Vine – General Manager Business Revenue.

Debbie Fortnum – General Manager Education. 

Dr Marie Ludlow BA (Hons) PhD – General Manager Health Outcomes and Evaluation. 

Anne Revell – General Manager Support. 

Names of Board Members

Kidney Health Australia Board of Directors

 

Mr David Morgan BA (Hons), M Int Law

Mr Morgan was appointed interim chair of the Board March 2016.

He retired from the Department of Foreign Affairs and Trade in 2014. He served overseas as a diplomat and represented Australia in international trade and environment organisations. His policy experience includes helping to develop Australia’s gene technology regime and other health and safety issues. From 2004 – 2009 Mr Morgan was a Visiting Fellow at the University of Melbourne.  He is the author/co-author of books and journal articles on the legal, economic and political aspects of biotechnology and other trade and environment issues. Mr Morgan is the Chair of the Emorgo Foundation and a Director of the Victorian Bridge Association. He received a kidney from his father in 1989.

 

Professor Allan Collins MD, FACP (Minnesota USA)

Professor Collins was appointed to the Board in December 2009.

With a distinguished background in nephrology and public health, he is the immediate past president of the National Kidney Foundation (NKF) and professor of medicine at the University of Minnesota School of Medicine, Hennepin County Medical Centre in Minneapolis. He also serves as a director of the Chronic Disease Research Group of the Minneapolis Medical Research Foundation and as principal investigator for the US Renal Data System Coordinating Centre of the National Institutes of Health. As the director of the NKF’s Kidney Early Evaluation Program (KEEP) Coordinating Centre, Professor Collins manages all data resulting from the KEEP screening programs nationwide. Professor Collins is also principal investigator for the Centres for Disease Control and Prevention’s chronic kidney disease detection program at state level. He has also participated in the World Health Organisation Research Agenda for Non-Communicable Diseases planning group and the Field Protocol Development Group for non-communicable disease management in low resource settings.

 

Professor Jonathan Craig PhD, MMed, FRACP, DipCH, MBChB

Professor Craig was appointed to the Board on 16 December 2011.

He is currently Honorary Medical Officer consultant at the Royal Prince Alfred Hospital; director of the Clinical Epidemiology Program at the School of Public Health, University of Sydney; senior staff specialist nephrology at the Children’s Hospital Westmead; co-chair of the Cochrane Collaboration; head of clinical research at the Centre for Kidney Research, Children’s Hospital, Westmead; and a member of the Protocol Advisory Sub-Committee of the Medical Services Advisory Committee.

 

Mr Peter Jon Hartshorne

Mr Hartshorne was appointed to the Board in April 2008.

He is currently managing partner and founder of The Infinity Group of companies (established 1994), a private professional services firm in Australia, India and UK. He is also chairman of Scholaris International Ltd, an international education-based software company, and Redgum Corporate Pty Ltd. Mr Hartshorne began his career with a six-year cadetship with McKinsey and Co and went on to work for many top 100 international companies in the areas of strategy and technology enablement. o Mr Hartshorne was appointed Acting Chair of the Audit and Risk Committee in March 2016.

 

Mr Graeme Holmes BEc, MBA

Mr Holmes was appointed to the Board in May 2007.

He has more than 30 years domestic and international experience in business and strategic planning and general management, industrial relations and strategic human resource management. As well as his years of work with Kidney Health Australia, Mr Holmes contributes his expertise to assist the charitable organisation the Prahran Mission. He is a member of our Audit and Risk Management Committee.

 

Mr Peter Mitchell

Mr Mitchell was appointed to the Board in May 2007.

He is currently commercial adviser to FMT Worldwide, an Australian-based software company. He also served for ten years on the Australian Advisory Board of the insurance group AIG International. His career spans 52 years in finance with the Commonwealth Bank and Perpetual Private Clients. Mr Mitchell was a long-serving committee member and board member of the Melbourne Cricket Club. He has also previously been a board member for seven years with Kids Help Line Australia and three years as a board member with the Lasallian Foundation (Asia Pacific).

 

Mr David Parker AM

Mr Parker was appointed to the Board in April 2010.

He is currently deputy secretary at the Department of Sustainability, Environment, Water, Population and Communities with particular responsibility for the Water Group, which leads the development and implementation of national policies and programs to achieve more sustainable management of Australia’s water resources. Mr Parker was formerly a member of the Executive Board of the Commonwealth Treasury, with responsibility as executive director of the Revenue Group and also as chair of the Treasury Audit Committee. His career at the Treasury spanned from 1984 until February 2011 and includes a period working with the OECD in Paris. Mr Parker was made a Member of the Order of Australia in January 2012.

 

Professor Carol Pollock MB BS PhD FRACP

Professor Carol Pollock was appointed to the Board in December 2014.

She trained as a specialist in Renal Medicine, and gained her PhD in renal physiology in 1992. She was appointed to the Professorial Chair of Medicine, University of Sydney, Royal North Shore Hospital in 2000. She is inaugural Chairman of the Board of the Northern Sydney Local Health District, which has oversight of 6 hospitals and the health of 1.7 million people in New South Wales. She is immediate past Chair, and currently serves on the Boards of the NSW Clinical Excellence Commission and the NSW Agency for Clinical Innovation.  She has published over 220 papers in the scientific literature. She was twice awarded the Australian and New Zealand Society of Nephrology (ANZSN) Young Investigator Award and in 2001 was awarded the highest scientific recognition of the ANZSN, the TJ Neale award. She has previously been a member of the NSW Ministerial Advisory Council for Science and Medical Research and regularly serves on the National Health and Medical Research Council Committees, both as a member and panel Chairman. She has been a member of the Executive Committee of the International Society of Nephrology and is the Scientific Chairman of the World Congress of Nephrology meeting to be held in Hong Kong in 2013. She serves on the Board of several not-for-profit organisations in the Health and Medical Research sector.

 

Mr Vin Harink B Bus, CA

Mr Haring was appointed to the Board in December 2004 (Appointed Chairman April 2010,  resigned March 2016).

He is currently a director of Colvin Management Pty Ltd, a consulting company in the property and finance sectors, and a director of Altus Traffic Pty Ltd. Until July 2008 he was the Chief Executive Officer of Austock Property Funds Management Limited and subsidiary entities. Mr Harink has more than 20 years experience in corporate finance, mergers and acquisitions and capital markets, as a director of Austock Corporate Finance Limited, a partner with Deloitte Touche Tohmatsu, a director of Deloitte Corporate Finance Limited and a director of KPMG Corporate Finance Pty Limited. Mr Hanrink is a member of the Audit and Risk Committee and Remuneration Committee.

Registration Information

ABN

37 008 464 426

Tax Deductible

Yes

How to Help us

Wills and Bequests

By remembering Kidney Health Australia in your will, you will be making a considerable difference to the lives of people with kidney disease and their families. It’s a way of showing that you care, knowing that your generosity will be remembered and appreciated. Details on how to leave a bequest, and appropriate wording for your will, visit our website www.kidney.org.au

 

Work with us

Volunteer with us

Volunteers provide valuable assistance in a variety of areas , including supporting administrative and fundraising projects.

 

Our Annual Reports

PRINT

Featured Not for Profits


A not-for-profit community based company which was formed in...


To achieve better health for vulnerable communities by accel...

Burnet Institute

Fitted for Work helps women experiencing disadvantage get wo...

Fitted for Work

Our mission is that all children with all types of neuroblas...

Neuroblastoma Australia

You Might Be Interested In

AON
pba inverse logo
Subscribe Twitter Facebook